Coronavirus: China allows use of HIV drug Azvudine for adult Covid-19 patients
China has given conditional approval for use of the HIV drug Azvudine to treat adults with Covid-19.
The National Medical Products Administration said in a notice on Monday that the drug, produced by Chinese pharmaceutical firm Genuine Biotech, could be used to treat the disease.
It widens the use of Azvudine, which was approved in July last year to treat people infected with the HIV-1 virus.
The drug will be the first Chinese-made oral antiviral drug to treat Covid-19. The regulator in February gave conditional approval for the use of Pfizer’s Covid-19 oral antiviral pill Paxlovid in China.